Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
IRAA Iris Acquisition Corp
10.1900.0000.00%
Close
01/27 16:00 ET
10.1900.0000.00%
Post Mkt Price 01/27 16:00 ET
High
0.000
Open
10.190
Turnover
205.00
Low
0.000
Pre Close
10.190
Volume
20.00
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Program CD47, Provided the CMC Service by GenScript ProBio to InnobationBio, Will Further Be Advanced by the Joint Venture Between Liminatus Pharma LLC and Iris Acquisition Corp
Iris Acquisition, Liminatus Pharma Sign SPAC Merger Deal
04:18 AM EST, 12/01/2022 (MT Newswires) -- Iris Acquisition Corp. (IRAA), a blank-check firm, and clinical-stage biopharmaceutical company Liminatus Pharma said late Wednesday that they have reached a
Liminatus Transaction Is Expected to Close in 1H 2023 >IRAA
Iris Acquisition to Combine With Liminatus Pharma
Combined Company Is Expected to Be Listed on Nasdaq Capital Market, Renamed Liminatus Pharma Inc >IRAA
Combined Company Is Expected to Be Listed on Nasdaq Capital Market, Renamed Liminatus Pharma Inc >IRAA
Transaction Values Combined Companies at Pro Forma Enterprise Value of $334M >IRAA
Transaction Values Combined Companies at Pro Forma Enterprise Value of $334M >IRAA
Liminatus Pharma, Iris Acquisition Corp. to Combine, Plan to Operate Under Liminatus Pharma >IRAA
Liminatus Pharma, Iris Acquisition Corp. to Combine, Plan to Operate Under Liminatus Pharma >IRAA
Liminatus Pharma, Iris Acquisition Corp. to Combine, Plan to Operate Under Liminatus Pharma >IRAA
Press Release: Liminatus Pharma LLC and Iris Acquisition Corp to Combine to Incorporate and Accelerate Much-needed Cancer Treatments
Liminatus Pharma LLC and Iris Acquisition Corp to combine to incorporate and accelerate much-needed cancer treatments Businesses announce Definitive Business Combination Agreement and plan to operate
With 57% Ownership, Iris Acquisition Corp (NASDAQ:IRAA) Boasts of Strong Institutional Backing
Company Overview
More
Iris Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on November 5, 2020 and is headquartered in San Francisco, CA.
CEO： Mr. Sumit Mehta
Market： NASDAQ
Listing Date： 03/05/2021
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet